Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
We now rank 3rd in pharmaceutical production by volume and 14th by value
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Potential of Ayurveda’s contribution in global health system through various innovative practices
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
Subscribe To Our Newsletter & Stay Updated
